Public health and bovine tuberculosis: what's all the fuss about? by Torgerson, P R & Torgerson, D
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2010
Public health and bovine tuberculosis: what's all the fuss about?
Torgerson, P R; Torgerson, D
Torgerson, P R; Torgerson, D (2010). Public health and bovine tuberculosis: what's all the fuss about? Trends in
Microbiology, 18(2):67-72.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Torgerson, P R; Torgerson, D (2010). Public health and bovine tuberculosis: what's all the fuss about? Trends in
Microbiology, 18(2):67-72.
Torgerson, P R; Torgerson, D (2010). Public health and bovine tuberculosis: what's all the fuss about? Trends in
Microbiology, 18(2):67-72.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Torgerson, P R; Torgerson, D (2010). Public health and bovine tuberculosis: what's all the fuss about? Trends in
Microbiology, 18(2):67-72.
Public health and bovine tuberculosis: what's all the fuss about?
Abstract
Bovine tuberculosis (bTB) in UK cattle is increasing rapidly. Consequently, the UK Government is
spending escalating sums of money in attempts at disease control. We propose that bTB control in cattle
is irrelevant as a public health policy. In the UK, cattle-to-human transmission is negligible. Aerosol
transmission, the only probable route of human acquisition, occurs at inconsequential levels when milk
is pasteurised, even when bTB is highly endemic in cattle. Furthermore, there is little evidence for a
positive cost benefit in terms of animal health of bTB control. Such evidence is required; otherwise,
there is little justification for the large sums of public money spent on bTB control in the UK.
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OpinionGlossary
Cost–benefit analysis: the financial return of a control programme. A
programme where the financial benefit of intervention is less than the costs
of such an intervention has a negative cost benefit.
Cost-effectiveness: the cost of an intervention programme in terms of the
improvement in public health. Highly cost-effective programmes will result in
gains of many QALYs, or reduction in many DALYs lost, at modest cost.
DALY: Disability Adjusted Life Year. This is the measure of human population
health preferred by the World Health Organisation. One DALY is approximately
the loss of 1 year of healthy life. Although there are significant differences in
the way QALYs and DALYs are calculated, very generally if a disease results in
one DALY then there will be the loss of one healthy year of life or one QALY.
QALY: Quality Adjusted Life Year. This is a measurement of population health
used in health economics. One QALY is approximately 1 year of healthy life.
Spoligotype: a form of polymorphism in the repeat units of DNA. Spoligotyp-
ing of isolates of Mycobacterium is used to study the molecular epidemiology
of tuberculosis.
Test and cull policy: the method of bTB control in cattle. Cattle are tested with
the intradermal tuberculin test, and animals testing positive are culled whilstBovine tuberculosis (bTB) in UK cattle is increasing
rapidly. Consequently, the UK Government is spending
escalating sums of money in attempts at disease control.
We propose that bTB control in cattle is irrelevant as a
public health policy. In the UK, cattle-to-human trans-
mission is negligible. Aerosol transmission, the only
probable route of human acquisition, occurs at incon-
sequential levels when milk is pasteurised, even when
bTB is highly endemic in cattle. Furthermore, there is
little evidence for a positive cost benefit in terms of
animal health of bTB control. Such evidence is required;
otherwise, there is little justification for the large sums
of public money spent on bTB control in the UK.
Control and re-emergence of tuberculosis in
British cattle
Historically, tuberculosis caused by Mycobacterium bovis
(bovine tuberculosis, bTB) was a major public health issue
in the UK. bTB in humans was widespread in the UK
before the introduction of pasteurisation of milk in the
1960s: in the 1930s, 40% of dairy cows were infected and
0.5% had tuberculous mastitis [1]. During this period,
approximately 2500 people died annually from bTB. There-
fore, measures were introduced to eliminate bTB from the
UK.Asa result, by the1970s, bTBwaseliminated frommost
of Britain, with persistent infection limited to the southwest
[1]. Subsequently, bTB has re-emerged: in 2007, there were
4172 new herd breakdowns in England and Wales [2]. The
resurgence of bTB has resulted in public expenditure now
approaching £100 million annually (see http://www.defra.
gov.uk/animalh/tb/stats/expenditure.htm). More and more
extreme measures are being proposed to stop the spread of
the disease such aswidespread badger culling programmes,
despite scientific studies castingdoubt on the efficacyof such
practices [3].
We argue that, apart from milk pasteurisation, these
measures no longer make economic sense and hence are
now resulting in gross misallocation of public resources.
We are therefore of the opinion that there is no public
health rationale for the multimillion bTB control pro-
gramme in the UK provided that milk continues to be
pasteurised. The logical conclusion arising from this is
that without a public health perspective, bTB is essentially
an endemic animal disease and hence any control pro-
gramme should be economically effective in terms ofCorresponding author: Torgerson, P.R. (ptorgerson@vetclinics.uzh.ch)
0966-842X/$ – see front matter  2009 Elsevier Ltd. All rights reserved. doi:10.1016/j.tim.2009.improvements in animal health and welfare and industry
profitability or viability.
Transmission of bTB to humans rarely occurs in the UK
Before milk pasteurisation,M. bovis was isolated from 8%
of churn samples and almost all 3000-gallon tankers [4]
suggesting widespread exposure to bTB. Since milk pas-
teurisationwas generally introduced in the UK in the early
1960s, bTB in humans has declined dramatically. Between
1993 and 2003, 315 human cases of bTB were confirmed
[5]. Among the affected people, only 14 had been born in the
UK after 1960, whereas most of them had been born either
before 1960 (265 cases) or outside of the UK (36 cases).
Molecular epidemiological studies of bTB have been uncon-
vincing in terms of the present threat ofM. bovis to human
health. A genetic analysis of all 50 M. bovis isolates of
human cases of bTB between 1997 and 2000 produced 25
individual spoligotypes (see Glossary) [6]. Of these, 15
spoligotypes had not been recorded in UK cattle,
suggesting that they had not been transmitted from the
animals, and were possibly the result of reactivation of old
lesions in individuals that were infected 50 years pre-
viously with the spoligotype then circulating in British
cattle. Indeed, 72% of subjects from which M. bovis was
isolated were over 50 years old. The only proven case of
recent transmission from cattle to humans in the UKwas a
cluster of two cases on a Gloucestershire dairy farm [7]. A
further case in Cornwall has been described recently which
might also have been transmitted from British cattle [8].the remainder of the herd is put on restrictions until the whole herd tests
negative.
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Table 1. Presence of M. bovis in pulmonary TB, as reported in
African studiesa
Country Samples with
Mycobacterium spp.
Samples with
M. bovis
Ref.
Cameroon 455 1 [54]
Ivory Coast 346 0 [55]
Ghana 64 2 [56]
Nigeria 357 3 [57]
Sierra Leone 97 0 [58]
Burundi 170 0 [12]
Burkina Faso 120 0 [15]
Nigeria 65 10 [59]
abTB control in cattle is generally neglected in Africa. Of 55 African countries, bTB
control is undertaken inadequately, if at all, in 48 countries [53].
Opinion Trends in Microbiology Vol.18 No.2The patient was a veterinary nurse and had the same
spoligotype that was isolated in local cattle. Remarkably,
local farmers, with a much higher contact rate with cattle,
were not infected and, therefore, other means of trans-
mission (such as from badgers via the household dog) are
possible. Finally, there is a recent cluster of six cases
reported in Birmingham [9]. All of these patients, linked
to each other by contact, were young, indigenous to the UK
and had a spoligotype that is common in UK cattle. One of
them, possibly the primary case, had a history of unpas-
teurised milk consumption and contact with cattle both in
the UK and overseas. It appears that transmission be-
tween these six people was likely to have been by aerosol.
Human-to-human transmission of bTB is an exceptional
event in the absence of immunosuppression [4]. However,
four of the six patients were probably immunocompro-
mised, and transmission likely occurred through repeated
contacts in confined environments.
bTB is a food borne disease in humans
Declining numbers of human cases despite massive
increases in affected cattle is consistent with the hypoth-
esis that bTB is a food borne disease transmitted by milk.
Indeed, a recent familiar outbreak of bTB in Ireland was as
a result of the consumption of unpasteurised milk [10].
Nevertheless, belief is widespread that transmission from
cattle to humans by aerosol is also important. For example,
Smith and Clifton-Hadley [11] concluded that bTB control
in cattle must continue to prevent cattle developing
advanced lesions resulting in increased aerosol trans-
mission to humans. However, evidence presented in Box
1 suggests that there was little bTB transmission by
aerosol from cattle to humans in the UK before bTB con-
trol. Contemporaneous evidence can also be examinedBox 1. Aerosol transmission of bTB from cattle to human
Pulmonary TB caused by M. bovis (bovine TB, bTB) was seldom
diagnosed in the UK in the early 20th century [4]. Between 1908 and
1937, a total of 194 human cases of bTB were described in Great
Britain (i.e. 6–7 cases per year) [44]. Of these 194, 38 had contact
with cattle, and it was hypothesised that the remainder might have
been infected through drinking milk. An analysis of 13 studies
corresponding to 938 cases of pulmonary TB showed that, of these,
932 were caused by M. tuberculosis, three by M. bovis and another
three were mixed infections [45]. Griffith and Smith [46] investigated
103 cases of pulmonary TB in NE Scotland and reported that 13
cases were bTB; the mode of infection was probably alimentary for
five of them.
An extensive report of 2101 cases of pulmonary TB from the
Cheshire sanatorium [47] represented the period 1934–1943. Of
these, just 48 cases (2.28%) were bTB and only 10 were strongly
suggestive of airborne transmission from cattle. Three cases were of
familial airborne transmission, 16 were alimentary acquired, and in
the remaining 19 cases the mode of transmission was not
elucidated. The study confirmed that pulmonary bTB is an occupa-
tional health risk: M. bovis was detected in 16.4% of diseased
individuals with cattle contact, whereas only 1.6% of patients
without cattle contact were positive for bTB. However, the study
also indicated that the absolute numbers of bTB transmission are
small even when the disease is highly endemic in the cattle.
Likewise, at a time in the USA when bTB in cattle reached its peak,
mycobacteria were isolated from 1220 human infections [48]. Of 680
cases of pulmonary TB, only two were caused by M. bovis. The
bacterium was also isolated in 99 other cases that consisted of extra-
pulmonary TB, usually in children.
68from countries that have no programmes for control of
bTB (Table 1). With the exception of a study from Nigeria,
pulmonary tuberculosis (TB) cases have very low isolation
rates forM. bovis. For some of these, however, the isolation
rate might be artificially low owing to the inclusion of
glycerol in the culture media, which can inhibit the growth
of M. bovis but not that of Mycobacterium tuberculosis.
However, other studies specifically looking for M. bovis
failed to find any (e.g. a study fromBurundi [12]). A further
example is from South Africa where the prevalence of bTB
exceeds 70% in African buffaloes in the southern part of the
Kruger National Park. Sputum samples from 206 employ-
ees at the national park were examined, including 34
believed to be at particular high risk (workers who had
direct, unprotected contact with tuberculous lesions or
excretions). M. bovis was not isolated, although two cases
of M. tuberculosis infection were diagnosed [13].
One of the very few studies that appears, at first inspec-
tion, to provide more convincing evidence for significant
airborne transmission is from Burkina Faso [14]. Out of 39
individuals of high occupational risk of exposure to M.
bovis, 37 had pulmonary TB. This group also had higher
pulmonary TB rates than groups not exposed to cattle. In
199 cattle owned by these individuals, 13 had lung lesions
that were confirmed to contain M. bovis. Unfortunately,
the human cases were based on hospital records and the
causal organism (i.e.M. bovis,M. tuberculosis or other) was
not recorded. A more recent study from the same country
[15] failed to find M. bovis in 120 samples of sputum that
were positive forMycobacterium spp., although it should be
noted that most of the cases were from urban areas (where
direct contact with cattle is less likely). A recent study from
Mexico might also provide some evidence of aerosol trans-
mission [16]. The researchers could isolate or culture
Mycobacterium spp. from 94 out of 255 samples from
patients symptomatic for TB.M. bovis was detected in five
sputum samples and eight urine or gastric juice samples. It
seems that 16% of Mexican dairy cows carryM. bovis [17].
In China, human bTB is a very low proportion of TB cases
in patients that come from districts where milk is pas-
teurised, with a much higher proportion being reported in
pastoral areas where raw milk is extensively consumed
[18], thus supporting the hypothesis that human bTB in
humans is primarily a food borne disease.
Finally, it should also be noted that isolation ofM. bovis
from sputum of individuals with TB falls far short of
proving that aerosol was the means of acquisition. The
Opinion Trends in Microbiology Vol.18 No.2evidence presented in Box 1 demonstrates that for many
cases of pulmonary bTB the primary lesion is elsewhere.
The economics of bTB
bTB control is big business. In 2007, there were 4172 new
herd breakdowns in England and Wales [2]. The official
figures probably underestimate the true numbers of cattle
affected by bTB owing to, for example, the lack of sensi-
tivity of surveillance at abattoirs [19]. Nevertheless, the
direct costs can be estimated as £13,981 per breakdown
[20]—overall in excess of £58 million. A detailed break-
down of expenditure [20] shows that expenditure is due to
programme implementation. No animal health costs (such
as loss of productivity in diseased animals) are reported.
Unfortunately, there are few studies which examine such
costs to animal health.
Although bTB control can provide some benefits to the
cattle industry, what is lacking are good cost-effective
studies in terms of animal health, welfare and pro-
ductivity. Given the evidence regarding the low public
health risk of this disease, such studies are required to
justify the expenditure on control. One of the few cost–
benefit analyses considering only effects on animal health
and production is from Spain and it was demonstrated that
bTB control is not economically efficient [21].
Another important consideration, if bTB were to be dis-
continued, is the economic effect of the blocking of live cattle
exports [22]. However, the cost of the bTB programme is in
excess of the value of such live exports from the UK [23]. In
addition, only a minority of the UK cattle population (1.4%)
is exported each year (approximately 140,000 out of 10
million animals) [24]. Thus, 98.6% of the industry would
be unaffected by any export ban imposed.
More [25] presents an extensive review regarding var-
ious policies and public/private cost sharing for animal
disease control. The degree of public sector financing would
depend upon whether the disease is zoonotic, the degree of
contagiousness, whether it is endemic or epidemic and the
economic losses associated with the disease. Although bTB
is zoonotic, we have argued that effective milk pasteurisa-
tion removes the threat of transmission to humans. There-
fore, the degree of public investment in additional control
measures should largely be guided by other concerns.
Consequently, it is vital that cost-effectiveness studies
are undertaken in terms of animal health. To justify
bTB control, there should be firm estimates of any positive
economic effects of the programme resulting from
increased animal productivity, health and welfare, and
they should exceed the implementation costs.
Comparisons have been made with the Foot and Mouth
Disease (FMD) Control Programme as a justification for
resource allocation for bTB control [22]. Indeed, it has been
demonstrated that the economic effects of FMD went far
beyond that of the animal disease but had bystander effects
on many parts of the community [26]. However, both the
direct and the indirect effects of FMD (such as mass cull of
animals with burning on open pyres and complete closure
of the local community during the control programme
control) should be considered for comparison. FMD is
not a fatal disease in livestock but results in substantive
production losses following recovery. Because it is not fatal,many low-income countries do not prioritise FMD control
[27]. The negative bystander effects of FMD control as seen
in Cumbria (NWEngland) would not have occurred, but for
the mass slaughter of animals and the severe movement
restrictions in the countryside that the FMD control policy
entailed. In addition, because of the widespread problems
caused by the FMD control policy, alternatives such as the
use of vaccines are being considered [28]. By the same
argument, alternatives for bTB control should be con-
sidered, including the necessity of control.
Misallocation of resources
Currently the UK invests large amounts of public resource
to prevent bTB, which is essentially an animal disease. In
the absence of data demonstrating economic benefits to
animal health, such investment is, in our opinion, a clear
example ofmisallocation of resources. If there are economic
benefits to agriculture, then the industry rather than the
tax payer should bear most of the costs because of the
principles of cost sharing such as those reviewed by More
[25]. From a public health perspective, routine vaccination
against TB using BCG (Bacillus Calmette-Gue´rin, an atte-
nuated strain of M. bovis) for UK schoolchildren was
stopped owing to its poor cost-effectiveness [29]. Our cal-
culations suggest that the cost for controlling bTB as a
public health policy exceeds any positive effect in public
health substantially (Box 2).
The reasons given by theUKgovernment for bTB control
include: (i) ‘‘to reduce the economic impact of bTB and
maintain public health protection and animal health and
welfare’’, and (ii) ‘‘to ensure minimal risks to public health
fromexposure tobTBthroughcontinuing cattle surveillance
and control, slaughterhouse inspections and heat treatment
of milk, occupational health controls and monitoring for
human cases of bTB’’ [30]. Yet, this public health benefit
is negligible provided thatmilk continues to be pasteurised.
Indeed, operating the bTB control programme has health
andsafety risks.An incidenceof 1.9 injuries to veterinarians
per 10,000 cattle tested has been reported in the USA [31].
Of these, 10%were serious injuries that required immediate
treatment, and one spinal cord injury was reported.
These public resources could be better spent on areas of
disease prevention that would have an important impact on
public health (or the tax burden on the UK population could
be reduced). Prevention of human disease is an important
role of the UK’s National Health Service (NHS) that, in our
opinion, isnotadequately funded.HIV/AIDS, for instance, is
an important long-term threat to the health of the UK
population, yet at £38 million current expenditure for its
prevention represents a real reduction compared with 10
years ago [32]. The cost-effectiveness of treatments used by
the UK healthcare system is informed by the National
Institute of Clinical Excellence (NICE) [33], which appears
tobeheavily influenced byeconomicdecision-making. Inter-
ventionsmust be both effective and cost-effective. We argue
that bTB control is neither (Box 2).
A new way forward
The results of the randomised trial of badger culling
(RTBC) in the UK suggested that badger culling is an
ineffective use of public money. Indeed, the evidence69
Box 2. Health economics of bTB control
Estimates of the public health costs in England and Wales can be
made should bTB control be abandoned. Pessimistic scenarios
assume that the prevalence in cattle would return to levels seen in
the early part of the 20th century with associated aerosol transmis-
sion to humans. Milk would continue to be pasteurised. In 1944,
Cutbil and Lynn [47] suggested an annual incidence of pulmonary
bTB in adults of approximately 1.6 and 0.2 per 100,000 in rural and
urban populations, respectively. In children, bTB nearly always was
extra-pulmonary [44]. The rural population of England and Wales is
10.5 million (2001 census) and no exposure of urban populations to
cattle is supposed. Assuming that the 1944 incidence in rural
populations would return, the upper limit of 168 cases of bTB per
year would occur. Historical evidence suggests at least half and
probably two-thirds of pulmonary bTB was primarily alimentary
infections. Hence, we estimate approximately 56 cases per year
arising by aerosol transmission. The 10 cases reported by Cutbil and
Lynn [47] that were probably as a result of airborne transmission
from cattle were in occupational risk groups (six farmers, three farm
labourers, one tanner). In 1950, the agricultural associated popula-
tion in the UK was 2.8 million, with a reduction to 910,000 by 2010
expected (see http://faostat.fao.org/site/552/default.aspx#ancor).
Therefore, the population at risk in the UK is now one-third of that
in 1950 and, hence, a prorate decrease in the numbers of bTB cases
would be expected. This yields an expected maximum number of
cases of approximately 19 per year.
In Texas, a case of TB was calculated to cost 1.4 QALYs (see
Glossary) [49]. In the UK, each case of human bTB is likely to cost
similar numbers of QALYs or DALYs. Thus, the £100 million per year
spent on bTB control is preventing approximately 26.6 DALYs, or
gaining 26.6 QALYs—that is £3.8 million per QALY saved or DALY
averted. Few treatments are authorised by the UK National Institute
of Clinical Excellence (NICE) for uses that exceed a cost per QALY
gained of £20–£30,000 [33]. Thus, the possible cost per QALY gained
of bTB control exceeds this benchmark by several orders of
magnitude. In contrast, treating cases as they arise would be much
less costly. In Germany, a case of pulmonary TB in an adult costs
approximately £16,700 (May 2009 exchange rate) [50]. Assuming
similar treatment costs on the NHS, the treatment cost of 19 cases
would be £317,300, which is 0.3% of the cost of the bTB programme.
It should be noted that, during the 1940s and 1950s, adults might
have possessed certain protection against pulmonary TB because of
previous exposure to M. bovis in milk as children [51]. This would
not be generally the case today, as drinking unpasteurised milk is
rare in the UK. Therefore, the abandonment of the bTB control
programme might result in a greater number of human bTB cases
than that estimated above. If this were to be correct, then the use of
BCG vaccination in humans at risk of infection could help to reduce
the number of bTB cases [52].
Opinion Trends in Microbiology Vol.18 No.2suggested that culling not only wastes resources but it
might worsen the problem [34] and is unlikely to be
economically effective [20]. However, it is also possible
that badger culling might have some positive effects, as
there have been criticisms of the interpretations of the
RTBC both in terms of statistics and study design (see Ref.
[35]). In addition, there is some evidence that there might
be a modest positive long-term effect once badger culling
ceases [36]. Initially the Government’s chief scientific offi-
cer discounted the results of the RTBC and recommended
culling of badgers—although the Government sub-
sequently decided that a badger cull was not appropriate
[37]. However, the whole issue is mired in controversy and
politics, in which the scientific message is in danger of
being lost. Nevertheless, the Welsh assembly is proposing
to undertake a badger cull [38] and the British Conserva-
tive party has indicated they would initiate a badger cull if
they win the next general election [39,40].70Our simple calculation (Box 2) suggests that the current
bTB elimination programme is extremely inefficient in
terms of public health protection. We have already argued
that an economic evaluation of the costs in animal health to
the livestock industry that strips out the costs of the test
and cull policy is also required. If there is a negative cost
benefit in terms of animal health, then theUKGovernment
should seek derogation from EU laws that compel member
states to draw up plans for the elimination of bTB on their
territories (e.g. Council Directive 77/391/EEC). This would
enable the UK to abandon attempts at eliminating the
disease from the UK cattle herd and develop alternative
measures for animal health protection. In any case, if the
tax payer should ‘‘only be expected to pay for genuine
public good’’, as suggested by the UK governments Depart-
ment for Environment, Food and Rural Affairs (DEFRA)
[30], then costs should be borne by the livestock industry.
What would happen if the bTB control programme was
abandoned in the UK? The disease would certainly
increase further in the national herd (which is occurring,
nevertheless, in the presence of the programme). Math-
ematical modelling might be able to predict the probable
final level of endemic stability in the cattle population.
However, farmers exporting animals or supplying raw
milk for human consumption could have a self-funded
programme. For others, bTB would be like most other
endemic cattle diseases, probably causing some pro-
ductivity losses, but farmers themselves could decide on
the economic consequences of such losses and hence any
intervention. Disease security on individual farms could be
implemented through cooperation of farmers with their
veterinarians. Possible use of the BCG vaccine could be
introduced for cattle as an interim measure whilst better
vaccines are being developed. Although BCG provides far
from complete protection to cattle, evidence suggests that if
given in the correct doses it can be used to reduce trans-
mission, particularly if given before calves have been
exposed to bTB [41]. As the test and cull policy would no
longer operate, use of BCG vaccine would not interfere
with this testing policy.
Concluding remarks
More and more extreme measures for the control of bTB
are largely supported by the farming industry and the
veterinary profession [42]. Ironically, in the first half of
the last century, farmers, consumers and legislators
repeatedly resisted attempts to make testing of cattle
and, more importantly, pasteurisation of milk compulsory
in Britain, despite overwhelming evidence (particularly
from the USA [43]) of its positive impact on public health.
In light of the evidence we have presented here, we
would propose that the continuing bTB programme in the
UK is economically unacceptable as a public health inter-
vention. Furthermore, data is lacking with regard to the
positive economic effects to animal health, given that the
main costs are implementation expenditure. Thus, the
most effective way of reducing the economic impact of
bTB is to stop the bTB control programme in its present
form. A shift away from prevention in cattle, whilst con-
tinuing with the regulation of milk and meat, should
provide adequate public health protection at relatively
Opinion Trends in Microbiology Vol.18 No.2modest costs. More and colleagues [35], when arguing in
defence of badger culling, concluded: ‘‘It is important that
interested policymakers and the general public are aware
of varying perspectives surrounding this topic.’’ We believe
it is also vital that policymakers and the general public are
aware of the alternative perspectives regarding the need
for bTB control, particularly from the public health
perspective.
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